Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Chronic Obstructive Pulmonary Disease”

432 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 432 results

Post-approval studies (Phase 4)Study completedNCT02424344
What this trial is testing

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
AstraZeneca 267
Large-scale testing (Phase 3)Study completedNCT00677807
What this trial is testing

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
Novartis 415
Not applicableLooking for participantsNCT06072690
What this trial is testing

Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease SevereCardiovascular Diseases+1 more
Lithuanian University of Health Sciences 80
Testing effectiveness (Phase 2)Study completedNCT01176903
What this trial is testing

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 65
Large-scale testing (Phase 3)Looking for participantsNCT06878261
What this trial is testing

Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 990
Testing effectiveness (Phase 2)Ended earlyNCT02461134
What this trial is testing

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Actelion 1
Post-approval studies (Phase 4)Study completedNCT01186653
What this trial is testing

Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Hull University Teaching Hospitals NHS Trust 22
Not applicableStudy completedNCT02024737
What this trial is testing

SILO2 (Signal Intensity Lung washOut)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sheffield Teaching Hospitals NHS Foundation Trust 5
Large-scale testing (Phase 3)UnknownNCT05213507
What this trial is testing

Inhaled Amikacin in Preventing AECOPD

Who this might be right for
COPDCOPD Exacerbation
Shanghai Zhongshan Hospital 136
Large-scale testing (Phase 3)Study completedNCT00056264
What this trial is testing

Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPD
Centocor, Inc. 234
Not applicableStudy completedNCT07664111
What this trial is testing

Ketogenic Dietary Intervention in Men With Mild-to-Moderate COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Agri Ibrahim Cecen University 34
Testing effectiveness (Phase 2)Study completedNCT01425814
What this trial is testing

Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 87
Large-scale testing (Phase 3)Study completedNCT01437397
What this trial is testing

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,692
Large-scale testing (Phase 3)Study completedNCT02487498
What this trial is testing

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 355
Large-scale testing (Phase 3)Study completedNCT01490125
What this trial is testing

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 247
Testing effectiveness (Phase 2)Study completedNCT07252908
What this trial is testing

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 195
Not applicableStudy completedNCT00879008
What this trial is testing

SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)

Who this might be right for
Chronic Bronchitis
Bayer 345
Testing effectiveness (Phase 2)Study completedNCT01049360
What this trial is testing

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 128
Large-scale testing (Phase 3)Study completedNCT01782326
What this trial is testing

QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 3,362
Large-scale testing (Phase 3)Study completedNCT01854658
What this trial is testing

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Pearl Therapeutics, Inc. 1,615
Next Page